Compounds > lysine
Page last updated: 2024-08-17

lysine and Prostatic Neoplasms, Castration-Resistant

lysine has been researched along with Prostatic Neoplasms, Castration-Resistant in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (40.00)24.3611
2020's6 (60.00)2.80

Authors

AuthorsStudies
Deng, Y; He, X; Hu, T; Huang, H; Kong, W; Liao, Y; Liu, Y; Shao, Z; Sun, W; Xia, X; Yu, C1
Azuma, H; Burton, F; Carducci, MA; Chakraborty, G; Chen, YH; Davicioni, E; Frank, D; Hirani, R; Kantoff, PW; Lee, GM; Liu, G; Mazzu, YZ; Nandakumar, S; Rajanala, SH; Stopsack, KH; Sweeney, CJ; Wang, XV; Yoshikawa, Y1
Allegrucci, C; Alsaleem, M; Brownlie, J; de Brot, S; Endeley, C; Fray, RG; Gudas, LJ; Haigh, DB; Haque, M; Harris, AE; James, VH; Jeyapalan, JN; Khani, F; Lothion-Roy, J; Madhusudan, S; Martin, LM; Metzler, VM; Mongan, NP; Moyer, JE; Ntekim, A; Persson, JL; Rakha, E; Robinson, BD; Rutland, CS; Toss, MS; Varun, D; Woodcock, CL1
Arrowsmith, CH; Besschetnova, A; Cai, C; Chen, S; Gao, S; Han, D; He, HH; Li, M; Liu, M; Macoska, JA; Patalano, S; Petricca, J; Siegfried, KR; Vedadi, M; Venkataramani, K; Wang, Z; Zhang, S1
Bazylianska, V; Brunzelle, JS; Chowdhury, DD; Edwards, BFP; Heath, EI; Hüttemann, M; Kalpage, HA; Kim, K; Lee, I; Mahapatra, G; Marcus, K; Morse, PT; Podgorski, I; Polin, L; Subedi, P; Turner, AA; Vaishnav, A; Wan, J1
Chen, L; Cheng, L; Li, X; Li, Y; Liu, B; Lu, D; Lv, F; Song, Y; Wang, D; Xing, Y; Yu, Y; Zhang, P1
Bénard, F; Cho, SY; Kim, CK; Pomper, MG; Rowe, SP; Valliant, J; Zukotynski, KA1
Holmberg, AR; Lennartsson, L; Marquez, M; Meurling, L; Nilsson, S1
Broos, W; Knol, R; van der Zant, F; Wondergem, M1
Allen, A; Cottard, F; Einsle, O; Greschik, H; Hermann, B; Hornung, V; Imhof, A; Jung, M; Maurer, J; Metzger, E; Obier, N; Offermann, A; Perner, S; Preca, BT; Schmidt, A; Schüle, R; Sum, M; Ulferts, S; Urban, S; Wang, S; Willmann, D1

Reviews

1 review(s) available for lysine and Prostatic Neoplasms, Castration-Resistant

ArticleYear
Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer.
    Frontiers in endocrinology, 2022, Volume: 13

    Topics: Androgen Antagonists; Androgens; Histone Demethylases; Humans; Lysine; Male; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen

2022

Other Studies

9 other study(ies) available for lysine and Prostatic Neoplasms, Castration-Resistant

ArticleYear
Selective degradation of AR-V7 to overcome castration resistance of prostate cancer.
    Cell death & disease, 2021, 09-21, Volume: 12, Issue:10

    Topics: Animals; Benzamides; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Flavones; Humans; Lysine; Male; Mice, Inbred BALB C; Mice, Nude; Models, Biological; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Proteasome Endopeptidase Complex; Proteolysis; Receptors, Androgen; Ubiquitin Thiolesterase; Ubiquitination

2021
Increased MYBL2 expression in aggressive hormone-sensitive prostate cancer.
    Molecular oncology, 2022, Volume: 16, Issue:22

    Topics: Androgen Antagonists; Androgens; Cell Cycle Proteins; Docetaxel; Histone Demethylases; Humans; Lysine; Male; Minor Histocompatibility Antigens; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Taxoids; Trans-Activators

2022
SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1.
    Proceedings of the National Academy of Sciences of the United States of America, 2023, 08-15, Volume: 120, Issue:33

    Topics: Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Hepatocyte Nuclear Factor 3-alpha; Histone Demethylases; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Male; Methyltransferases; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen

2023
Lysine 53 Acetylation of Cytochrome
    Cells, 2021, 04-03, Volume: 10, Issue:4

    Topics: Acetylation; Animals; Apoptosis; Cardiolipins; Caspase 3; Cell Line, Tumor; Crystallography, X-Ray; Cytochromes c; Electron Transport Complex IV; Humans; Lysine; Male; Mice; Molecular Dynamics Simulation; Mutation; Oxidation-Reduction; Oxygen Consumption; Peroxidase; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Reactive Oxygen Species; Warburg Effect, Oncologic; Xenograft Model Antitumor Assays

2021
KAT2A-mediated AR translocation into nucleus promotes abiraterone-resistance in castration-resistant prostate cancer.
    Cell death & disease, 2021, 08-12, Volume: 12, Issue:8

    Topics: Acetylation; Androstenes; Animals; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Histone Acetyltransferases; Humans; Lysine; Male; Mice, Nude; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Protein Transport; Receptors, Androgen; RNA, Messenger; Up-Regulation

2021
Flare on Serial Prostate-Specific Membrane Antigen-Targeted 18F-DCFPyL PET/CT Examinations in Castration-Resistant Prostate Cancer: First Observations.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:3

    Topics: Aged; Antigens, Surface; Glutamate Carboxypeptidase II; Humans; Lysine; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms, Castration-Resistant; Recurrence; Time Factors; Urea

2018
Synthesis and Binding of a Novel PSMA-specific Conjugate.
    Anticancer research, 2018, Volume: 38, Issue:3

    Topics: Antigens, Surface; Cell Line, Tumor; Dextrans; Fluorescein-5-isothiocyanate; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Lysine; Male; Microscopy, Fluorescence; Molecular Targeted Therapy; Prostatic Neoplasms, Castration-Resistant; Protein Binding; Radiopharmaceuticals; Urea

2018
Increased PSMA Expression in Castration-Resistant Prostate Cancer Metastases 3 Months After Initiation of Enzalutamide Indicated by 18F-DCFPyL PET/CT.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:7

    Topics: Antineoplastic Agents; Benzamides; Diagnosis, Differential; Humans; Lymphatic Metastasis; Lysine; Male; Nitriles; Phenylthiohydantoin; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals; Urea

2019
KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells.
    Nature structural & molecular biology, 2019, Volume: 26, Issue:5

    Topics: Cell Line, Tumor; Cell Proliferation; Dimerization; Histones; Humans; Lysine; Male; Methylation; Methyltransferases; Prostatic Neoplasms, Castration-Resistant; Site-Specific DNA-Methyltransferase (Adenine-Specific)

2019